Clearside Biomedical Inc (CLSD)
1.32
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.32
0.00 (0.00%)
After-Hours: 16:02
Clearside Biomedical Cash from Investing (TTM): -1.777M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.777M |
| September 30, 2023 | -1.748M |
| June 30, 2023 | -1.458M |
| March 31, 2023 | -0.361M |
| December 31, 2022 | -0.246M |
| September 30, 2022 | -0.155M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.055M |
| September 30, 2020 | -0.055M |
| June 30, 2020 | -0.055M |
| March 31, 2020 | 1.938M |
| December 31, 2019 | 32.92M |
| Date | Value |
|---|---|
| September 30, 2019 | 49.37M |
| June 30, 2019 | 49.74M |
| March 31, 2019 | 14.93M |
| December 31, 2018 | -3.76M |
| September 30, 2018 | -12.24M |
| June 30, 2018 | 0.457M |
| March 31, 2018 | 38.36M |
| December 31, 2017 | 20.12M |
| September 30, 2017 | -16.91M |
| June 30, 2017 | -50.05M |
| March 31, 2017 | -55.13M |
| December 31, 2016 | -49.14M |
| September 30, 2016 | -20.09M |
| June 30, 2016 | -0.024M |
| March 31, 2016 | -0.028M |
| December 31, 2015 | -0.028M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.777M
Minimum
Dec 2023
49.74M
Maximum
Jun 2019
6.74M
Average
--
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| Cassava Sciences Inc | -0.414M |
| Heron Therapeutics Inc | 18.00M |
| Actinium Pharmaceuticals Inc | -0.088M |
| Karyopharm Therapeutics Inc | 7.94M |
| Ocular Therapeutix Inc | -6.087M |